In kidney-alone recipients, dual-kidney transplantation using "higher-risk" donor organs has shown outcomes comparable to those of single-kidney transplantation using extended criteria donor (ECD) organs. To investigate the feasibility of a similar approach with combined kidney-liver transplantation, we identified 22 dual-kidney liver transplantations (DKLTs) and 3044 single-kidney liver transplantations (SKLTs) performed in the United States between 2002 and 2012 using United Network for Organ Sharing/Organ Procurement and Transplantation Network registry data. We compared donor/recipient characteristics as well as graft/recipient survival between DKLT recipients and SKLT recipients of "higher-risk" kidneys (ECD and high kidney donor profile index [KDPI; >85%] donors). Despite having overall similar donor and recipient characteristics compared with both "higher-risk" donor groups, recipient survival in the DKLT group at 36 months was markedly inferior at 40.9% (compared with 67.5% for ECD SKLT recipients and 64.5% for high-KDPI SKLT recipients); nondeath-censored graft survival did not differ. Death was the most common cause of graft loss in all groups. Contrary to dual-kidney transplantation data in kidney-alone recipients, DKLT recipients in our study had inferior survival when compared with SKLT recipients of "higher-risk" donor kidneys. These findings would suggest that dual kidney-liver transplantation has an uncertain role as a strategy to expand the existing kidney donor pool in combined transplantation.
Original article | 1571 recipient population that may not uniformly benefit from the combined procedure. (5) As with traditional solitary organ deceased donor kidney transplantation, conscientious use of donor kidneys for combined liver-kidney transplantation is imperative, particularly in the context of the current organ shortage.
In patients awaiting kidney transplantation alone, some studies have evaluated an approach that involves transplanting both kidneys from a single donor when an individual kidney from such a donor may be deemed unsuitable and discarded. Transplanting both kidneys together is thought to offset the decrease in quality, with some studies demonstrating comparable recipient outcomes to those seen with single-kidney transplantation using extended criteria donor (ECD) organs. (6, 7) Recently, a case-control study by Di Laudo et al. (8) explored the feasibility of applying a similar strategy in simultaneous liver-kidney recipients, comparing patients who received simultaneous dual-kidney liver transplantation (DKLT) with those receiving simultaneous single-kidney liver transplantation (SKLT) at a single center in Italy. Although limited by a small sample size and short follow-up time, the results were encouraging, observing no difference in 90-day mortality, incidence of selected postoperative complications, or graft and patient survival with a median follow-up time of 236 days in the DKLT arm. To further investigate this approach in the United States, we analyzed national registry data to evaluate DKLT and SKLT transplants performed between 2002 and 2012, corresponding to the decade after the introduction of the MELD score.
Patients and Methods
We used United Network for Organ Sharing (UNOS)/ Organ Procurement and Transplantation Network (OPTN) liver and kidney registry data to analyze a population of simultaneous liver-kidney recipients who underwent transplantation between February 2002 and December 2012. This was done by identifying recipients who received both a liver and kidney(s) from the same deceased donor. We did not differentiate by procedure type, and both en bloc and sequential transplants were included. We excluded all recipients under the age of 18 years old, those with prior liver or kidney transplants, and those who received any other organs at the time of transplantation. In this manner, we identified a cohort of 3044 SKLTs and 22 DKLTs performed during the study period. DKLTs were performed at 15 US transplant centers; 2 centers accounted for 3 procedures each with the remaining centers performing between 1 and 2 procedures over the 10-year period. The small sample size precluded analysis of center variation. Donor and recipient baseline characteristics as well as patient and renal graft outcomes were compared between the DKLT cohort and 3 predetermined comparison groups: the entire SKLT cohort (SKLT/ ALL, n = 3044) and 2 higher-risk donor subgroups, defined as SKLT using organs from ECDs (SKLT/ ECD, n = 370) or organs having a kidney donor profile 
Results
We identified 3066 simultaneous liver-kidney transplants performed during our study period. Of these, the vast majority were SKLTs (n = 3044), and a minority were DKLTs (n = 22; Fig. 1 Table 2 summarizes demographic characteristics for dual-and single-kidney liver donors as well as both higher-risk donor subgroups. Notably, DKLT donors were older compared with SKLT donors (median age 62 versus 35 years for SKLT/ALL donors; P < 0.001) but not compared with either of the higher-risk donor subgroups. Mean eGFR in the DKLT donors (63.2 ± 21.6 mL/minute) was lower compared with SKLT/ALL donors (92.3 ± 32.7 mL/minute; P < 0.001) but did not differ significantly from that of SKLT/ECD (73.1 ± 25.2 mL/minute; P = 0.06) or SKLT/high-KDPI donors (65.4 ± 23.3 mL/minute; P = 0.75). There was a higher incidence of hypertension and diabetes in the DKLT donors (68.2% and 18.2%, respectively) compared with SKLT/ALL donors (21.5% and 4.5%, respectively; P < 0.05 for both comparisons), but not compared with either of the higher-risk organ groups. Mean kidney cold ischemia times were higher for DKLT donor kidneys (13.5 ± 3.9 hours) compared with SKLT/ALL kidneys Original article | 1573 (11.6 ± 6.8 hours; P = 0.005), SKLT/ECD kidneys (11.8 ± 7.8 hours; P = 0.006), and SKLT/high-KDPI kidneys (11.0 ± 6.5 hours; P = 0.002). Liver cold ischemia times were also longer for DKLT livers (8.2 ± 3.1 hours) compared with SKLT/ALL livers (7.0 ± 3.7 hours; P = 0.03) and SKLT/high-KDPI livers (6.9 ± 3.9 hours; P = 0.02), but not SKLT/ ECD livers (7.3 ± 4.8 hours; P = 0.06).
BaSeline DOnOr characteriSticS
Metrics of donor organ quality, including the KDPI used by the new kidney allocation system and the liver-centric donor risk index (DRI) proposed by Feng et al., (10) were both significantly higher in the DKLT donor group compared with the SKLT/ALL cohort (corresponding to lower organ quality). The mean KDPI of SKLT/ALL donors was 39% (compared with 85% for DKLT donors; P < 0.001). Mean KDPI and DRI scores did not significantly differ between the DKLT cohort and either of the higher-risk donor groups, though the SKLT/ECD group did contain statistically fewer donors with KDPI scores >85% (51.2% versus 72.7% in the DKLT group; P = 0.049). between the groups. Pretransplant characteristics, including prevalence of diabetes, history of hepatitis C virus (HCV) infection, MELD score, and time on the kidney/liver waiting lists, were also statistically similar. Between 60% and 70% of the patients in each group were on dialysis at the time of transplant, and there was no difference in pretransplant dialysis duration (either in terms of median days on dialysis or as proportion of candidates who were on dialysis for >6 weeks prior to transplant). For patients not on dialysis at the time of transplant, the mean SCr was also similar between groups.
BaSeline recipient characteriSticS

pOStOperative OUtcOmeS anD SUrvival
Postoperatively, there was no significant difference between the DKLT and any of the SKLT subgroups with regard to incidence of delayed graft function or SCr at discharge (Table 4) . Longterm outcomes demonstrated more disparity. DKLT recipient survival at 3, 12, and 36 months (77.3%, 63.6%, 40.9%, respectively) was inferior to that of SKLT/ALL recipients (93.5%, 86.4%, 78.2%, respectively; P < 0.01 for all comparisons; Fig.  2 ). When compared with the higher-risk donor subgroups, mortality at 3 and 12 months did not statistically differ. However, at 36 months both higher-risk subgroups demonstrated better survival with 67.5% of SKLT/ECD and 64.5% of SKLT/high-KDPI recipients still living compared with 40.9% in the DKLT group (P = 0.006 and P = 0.02, respectively). In the DKLT group, the most common cause of death during the observation period was multiorgan failure, occurring in 4 of 13 patients, and infection, occurring in 3 of 13 patients. All-cause renal graft loss was significantly higher for DKLT recipients compared with SKLT/ALL recipients (Fig. 3) . At 12 months, only 65.8% of DKLT recipients still had functioning renal grafts (compared with 84.2% of the SKLT/ALL recipients; P = 0.01), dropping to 43.9% at 36 months (compared with 75.7% of SKLT/ALL recipients; P < 0.001). In contrast, rates of all-cause graft loss observed in the higher-risk SKLT subgroups did not significantly differ from that seen in DKLT recipients. The predominant cause of graft loss in DKLT recipients was death, occurring in 11 of 12 recipients who experienced graft failure events during the observation period. One DKLT recipient was lost to follow-up at 272 days before dying from unknown causes with uncertain renal graft function at 811 days (26.6 months) after transplant. This recipient was censored beyond his/her last follow-up date in the kidney graft survival analysis, making the graft survival appear to exceed the recipient survival at 36 months.
Discussion
DKLT is infrequently performed and represents only a small minority of simultaneous liver-kidney transplants each year. In our analysis, DKLT recipients fared poorly overall. Recipient survival at 36 months with DKLT was significantly worse compared with patients who received SKLT, even when comparison is limited to those recipients receiving higher-risk donor organs (ECD and KDPI >85%).
The reasons for the poor outcomes among DKLT recipients are unclear because there were no obvious differences in recipient characteristics and few differences in donor characteristics between DKLT recipients and either of the higher-risk SKLT groups. Recipients of DKLT in our study were similar to their SKLT counterparts across a broad range of metrics, including age, MELD score, BMI, and dialysis dependence/duration. Although donor organs going to DKLT recipients demonstrated higher-risk characteristics compared with those going to SKLT recipients overall, there were fewer differences when the comparison was narrowed only to ECD and high-KDPI organs. In fact, neither the KDPI nor DRI scores differed significantly between organs going to DKLT recipients and ECD and "high-KDPI" organs going to SKLT recipients. It is worth noting that both kidney and liver cold ischemia times were generally longer in the DKLT cohort (even when compared with higher-risk SKLT recipients). The reasons for this are not immediately clear although they may relate to the logistics of dual-kidney allocation. Although the incidence of delayed graft function did not significantly differ between groups, the extent to which longer cold ischemia times may have impacted longterm outcomes observed in the study is not fully understood. It is also possible, although not substantiated by our analysis, that increased operative time or surgical complexity in performing a DKLT may have played a contributory role in the low patient survival observed.
The predominant cause of graft failure in all arms was death, and the scarcity of nondeath-related graft failure events in the DKLT arm makes it challenging to draw any significant conclusions about graft longevity in our analysis. It is worth noting that graft survival not censored for death did not statistically differ between DKLT recipients and SKLT recipients of higher-risk donor organs, perhaps suggesting that higher rates of graft failure seen in higher-risk donor organ SKLT recipients may offset the increased mortality seen in DKLT recipients, though this finding would have limited clinical implications. In the context of an increasing kidney wait-list population and shortage of donor organs, however, the high death rate among DKLT recipients raises questions about whether dual kidneys might be more appropriately directed toward kidney-alone recipients.
Our results contrast sharply with those seen in the study by Di Laudo et al. (8) However, it is worth noting Original article | 1577 several differences that make direct comparison of our results more challenging. Recipients who underwent DKLT in that study were selected using uniform criteria previously determined by the transplant center and surgeries were performed using a uniform surgical approach. This reduces a number of potential confounders and may contribute to better postoperative and longterm outcomes, particularly in light of procedural complexity. In contrast, our cohort draws on a larger sample of transplants performed at multiple centers across the United States over a period of 10 years, introducing considerable variability in both recipient selection and surgical methodology. In addition, there are several differences between the donor/recipient populations in our respective cohorts. In particular, donors in our study had higher DRI scores and recipients had higher MELD scores, both parameters which have been identified as independent predictors of postoperative mortality in liver-alone transplantation. The BMI of recipients in our study was also higher.
Overall, our findings would suggest that combined DKLT has an uncertain role as a strategy to expand the existing kidney donor pool in combined transplantation. Contrary to literature on dual-kidney transplantation in kidney-alone candidates, DKLT recipients in our cohort experienced inferior survival when compared with SKLT recipients of higher-risk donor organs despite having similar recipient characteristics. We recognize that the decision to proceed with DKLT rather than waiting for a more suitable donor kidney is complex and may relate to a variety of transplant center and recipient considerations. However, in light of our findings, we would argue for caution in its routine use, especially in recipients with higher MELD scores.
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